← Eichor
Condition: Prostate Cancer Recurrent Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Prostate Cancer Recurrent

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recu
Phase 2 · 1 location(s) · Mayo Clinic · NCT07073794High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy
Phase N/A · 1 location(s) · Clinica Universidad de Navarra, Universidad de Navarra · NCT06982469Rezvilutamide in Patients With Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
Phase 2 · 2 location(s) · The Affiliated Nanjing Drum Tower Hospital of Nanjing Univer · NCT05753566Study of 18F-Florastamin PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer
Phase 3 · 1 location(s) · HTA Co., Ltd. · NCT06754085MRI/Ultrasound Fusion Guided Prostate Cryotherapy
Phase N/A · 1 location(s) · Urological Research Network, LLC · NCT02381990Stereotactic Re-irradiation of Local Recurrences of Prostate Cancer After Radiotherapy
Phase 2 · 1 location(s) · Maria Sklodowska-Curie National Research Institute of Oncolo · NCT06201078Flotufolastat F 18 PET in Men With Very Low PSA Recurrence
Phase N/A · 2 location(s) · Massachusetts General Hospital · NCT06862856HS-10502 Combination Treatment in Patients With Advanced Solid Tumors
Phase 1 · 1 location(s) · Jiangsu Hansoh Pharmaceutical Co., Ltd. · NCT06769425Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy
Phase 3 · 1 location(s) · yair lotan · NCT02064673Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabol
Phase 2 · 1 location(s) · City of Hope Medical Center · NCT07202247Salvage Ultrahypofractionated Postoperative External Radiotherapy For Biochemical Recurrence
Phase N/A · 1 location(s) · University of Milano Bicocca · NCT06941363Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro)
Phase 2 · 11 location(s) · Swiss Cancer Institute · NCT07365423Salvage MR-guided High-Dose-Rate Brachytherapy for Prostate Bed Recurrence After Radiotherapy in the PSMA PET Scan Era
NA · 1 location(s) · University Health Network, Toronto · NCT06508567Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT05588128SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma
Phase 3 · 6 location(s) · Mayo Clinic · NCT06205316Focal Salvage Brachytherapy Study (FocaSaBra)
NA · 1 location(s) · The Greater Poland Cancer Centre · NCT05715502Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy
Phase N/A · 3 location(s) · University of Erlangen-Nürnberg Medical School · NCT07131956PSMA Guided Approach for bIoCHEmical Relapse After Prostatectomy-PSICHE
Phase N/A · 1 location(s) · Azienda Ospedaliero-Universitaria Careggi · NCT05022914Comparing "Salvage" Radiotherapy and Individualized PSMA PET/CT Targeted Treatment in With Relapsing Prostate Cancer
Phase 3 · 5 location(s) · Stefan Carlsson · NCT04794777An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Phase 3 · 147 location(s) · Novartis Pharmaceuticals · NCT05939414Early Prostate Cancer Recurrence With PSMA PET Positive Unilateral Pelvic Lesion(s)
NA · 1 location(s) · Martini-Klinik am UKE GmbH · NCT04271579This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surger
Phase 2 · 1 location(s) · University of Rochester · NCT05946824Metastasis-directed Therapy for Oligorecurrent Prostate Cancer
Phase 3 · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT05352178PSMA-PET Guided Hypofractionated Salvage Prostate Bed Radiotherapy
Phase 3 · 13 location(s) · University Medical Center Groningen · NCT04642027Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivati
Phase 2 · 3 location(s) · Mayo Clinic · NCT06378866An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Complete
Phase 2 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT07185165PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer
Phase 2 · 1 location(s) · University of Nebraska · NCT07234981Head-to-head Comparison of [18F]AlF-PSMA-N5 With [18F]F-DCFPyL PET/CT in PCa Diagnosis, Recurrence, and Metastasis
EARLY_Phase 1 · 1 location(s) · Anhui Provincial Hospital · NCT06756334PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence
Phase 2 · 1 location(s) · AdventHealth · NCT06617481An Investigational Scan (rhPSMA-7.3 PET/CT) for Detecting Biochemically Recurrent Prostate Cancer, ENLIGHTEN Trial
EARLY_Phase 1 · 1 location(s) · Northwestern University · NCT06813898
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.